IMMULITE 2500
Report
- Report Number
- 2247117-2010-00018
- Event Type
- Other
- Date Received
- June 28, 2010
- Date of Event
- April 28, 2010
- Report Date
- June 1, 2010
- Manufacturer
- SIEMENS HEALTHCARE DIAGNOSTICS INC
- Product Code
- JJQ
- PMA / PMN Number
- K905215
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- GM
- Reporter Occupation
- OTHER HEALTH CARE PROFESSIONAL
Narratives
A SIEMENS HEALTHCARE FIELD SERVICE ENGINEER (FSE) WAS SENT TO THE CUSTOMER SITE FOR INSTRUMENT EVALUATION. ANALYSIS OF THE INSTRUMENT AND THE INSTRUMENT DATA INDICATE THAT THE CAUSE FOR THE DISCORDANT IPTH, FT3 AND FT4 RESULTS CANNOT BE DETERMINED. THE INSTRUMENT IS PERFORMING WITHIN SPECIFICATIONS. NO FURTHER EVALUATION OF THE DEVICE IS REQUIRED.
DISCORDANT IMMULATE 2500 IPTH, FT3 AND FT4 RESULTS WERE OBTAINED ON PT SAMPLES. THE SAMPLES WERE REPEATED BECAUSE THE INITIAL RESULTS DID NOT AGREE WITH THE PTS CLINICAL HISTORY. PT TREATMENT WAS NOT ALTERED OR PRESCRIBED FOR EITHER PT. THERE WAS NO REPORT OF ADVERSE HEALTH CONSEQUENCES DUE TO THE DISCORDANT IPTH, FT3 AND FT4 RESULTS.
A SIEMENS HEALTHCARE FIELD SERVICE ENGINEER (FSE) WAS SENT TO THE CUSTOMER SITE FOR INSTRUMENT EVALUATION. ANALYSIS OF THE INSTRUMENT AND THE INSTRUMENT DATA INDICATE THAT THE CAUSE FOR THE DISCORDANT IPTH, FT3 AND FT4 RESULTS CANNOT BE DETERMINED. THE INSTRUMENT IS PERFORMING WITHIN SPECIFICATIONS. NO FURTHER EVALUATION OF THE DEVICE IS REQUIRED.
DISCORDANT IMMULATE 2500 IPTH, FT3 AND FT4 RESULTS WERE OBTAINED ON PT SAMPLES. THE SAMPLES WERE REPEATED BECAUSE THE INITIAL RESULTS DID NOT AGREE WITH THE PTS CLINICAL HISTORY. PT TREATMENT WAS NOT ALTERED OR PRESCRIBED FOR EITHER PT. THERE WAS NO REPORT OF ADVERSE HEALTH CONSEQUENCES DUE TO THE DISCORDANT IPTH, FT3 AND FT4 RESULTS.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | IMMULITE 2500 | IMMUNO-ASSAY | JJQ | SIEMENS HEALTHCARE DIAGNOSTICS INC | NA | NA |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | ||||
| 2 |